Real-time Pressure Volume Loop Monitoring as a Guide for Enhanced Understanding of Changes in Elemental Cardiovascular Physiology During Therapeutic Strategies Aiming for Hemodynamic Optimization. Cohort I: Veno-arterial Extracorporeal Membrane Oxygenation (PLUTO-I)
Recruiting
- Conditions
- Cardio/Pulm: Heart FailureExtracorporeal Membrane Oxygenation
- Interventions
- Other: Pressure-volume loop measurements
- First Posted Date
- 2023-06-18
- Last Posted Date
- 2024-01-05
- Lead Sponsor
- Erasmus Medical Center
- Target Recruit Count
- 20
- Registration Number
- NCT05909280
- Locations
- 🇳🇱
Erasmus Medical Center, Rotterdam, Zuid-Holland, Netherlands
Standardising Care for Hepatitis Delta in the Netherlands
Recruiting
- Conditions
- Hepatitis D
- First Posted Date
- 2023-06-15
- Last Posted Date
- 2024-04-03
- Lead Sponsor
- Erasmus Medical Center
- Target Recruit Count
- 80
- Registration Number
- NCT05903742
- Locations
- 🇳🇱
Erasmus MC, Rotterdam, Netherlands
Actium-225-Prostate Specific Membrane Antigen Imaging & Therapy
Phase 1
Recruiting
- Conditions
- Prostatic Neoplasms, Castration-Resistant
- Interventions
- Radiation: Radionuclide Therapy
- First Posted Date
- 2023-06-13
- Last Posted Date
- 2023-06-13
- Lead Sponsor
- Erasmus Medical Center
- Target Recruit Count
- 30
- Registration Number
- NCT05902247
- Locations
- 🇳🇱
Erasmus Medical Center, Rotterdam, Zuid-Holland, Netherlands
TEIPP Immunotherapy in Patients With NSCLC
Phase 1
Completed
- Conditions
- Non Small Cell Lung Cancer
- Interventions
- Drug: TEIPP24 (LRPAP7-30V-SLP vaccine in Montanide ISA-51)
- First Posted Date
- 2023-06-12
- Last Posted Date
- 2024-11-07
- Lead Sponsor
- Erasmus Medical Center
- Target Recruit Count
- 26
- Registration Number
- NCT05898763
- Locations
- 🇳🇱
Leiden University Medical Center, Leiden, Zuid-Holland, Netherlands
🇳🇱Erasmus Medical Center, Rotterdam, Zuid-Holland, Netherlands
Effect of a Bigger Cryoballoon on the Total Antral Lesion Size: Evaluation of POLARx FIT
Not Applicable
Active, not recruiting
- Conditions
- Atrial Fibrillation
- Interventions
- Device: POLARx FIT cryoballoon
- First Posted Date
- 2023-05-31
- Last Posted Date
- 2024-11-07
- Lead Sponsor
- Erasmus Medical Center
- Target Recruit Count
- 20
- Registration Number
- NCT05881733
- Locations
- 🇳🇱
Erasmus Medical Center, Rotterdam, Zuid-Holland, Netherlands
Improving Peptide Receptor Radionuclide Therapy With PARP Inhibitors
Phase 1
Recruiting
- Conditions
- Neuroendocrine TumorsPeptide Receptor Radionuclide Therapy
- Interventions
- First Posted Date
- 2023-05-23
- Last Posted Date
- 2023-05-23
- Lead Sponsor
- Erasmus Medical Center
- Target Recruit Count
- 24
- Registration Number
- NCT05870423
- Locations
- 🇳🇱
Erasmus MC, Rotterdam, South Holland, Netherlands
Generation R Next - Optimaal Opgroeien
Not Applicable
Recruiting
- Conditions
- Pregnancy EarlyRisk Reduction BehaviorOutcome, Adverse BirthLifestyle FactorsPreconception CarePregnancy OutcomePregnancy Complications
- First Posted Date
- 2023-05-23
- Last Posted Date
- 2023-05-23
- Lead Sponsor
- Erasmus Medical Center
- Target Recruit Count
- 1750
- Registration Number
- NCT05870878
PCT-guided Treatment Regarding Antibiotic Use for Acute COPD Exacerbations
Not Applicable
Recruiting
- Conditions
- Acute Copd ExacerbationCOPD ExacerbationCOPD
- Interventions
- Diagnostic Test: ProcalcitoninOther: Physician's decision
- First Posted Date
- 2023-05-11
- Last Posted Date
- 2023-05-11
- Lead Sponsor
- Erasmus Medical Center
- Target Recruit Count
- 693
- Registration Number
- NCT05854901
- Locations
- 🇳🇱
Bravis hospital, Roosendaal, Noord-Brabant, Netherlands
🇳🇱Amphia hospital, Breda, Noord-Brabant, Netherlands
🇳🇱Catharina hospital, Eindhoven, Noord-Brabant, Netherlands
Morphine IV vs Paracetamol IV in Neonates and Infants After Cardiac Surgery
Not Applicable
Completed
- Conditions
- AnalgesiaCongenital Heart DiseaseSurgery
- Interventions
- First Posted Date
- 2023-05-10
- Last Posted Date
- 2023-05-10
- Lead Sponsor
- Erasmus Medical Center
- Target Recruit Count
- 208
- Registration Number
- NCT05853263
Evaluation of the Novel Therapeutic Hepatitis B Virus Synthetic Long Peptide Vaccination ISA104
- First Posted Date
- 2023-05-03
- Last Posted Date
- 2024-02-20
- Lead Sponsor
- Erasmus Medical Center
- Target Recruit Count
- 24
- Registration Number
- NCT05841095
- Locations
- 🇳🇱
Erasmus MC, Rotterdam, Netherlands
© Copyright 2025. All Rights Reserved by MedPath